Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study
Authors
Keywords
-
Journal
LUNG
Volume 201, Issue 4, Pages 355-362
Publisher
Springer Science and Business Media LLC
Online
2023-08-02
DOI
10.1007/s00408-023-00640-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating adipokine concentrations and the risk of venous thromboembolism: A Mendelian randomization and mediation analysis
- (2023) Weizhong Xiao et al. Frontiers in Genetics
- Obesity and the Development of Lung Fibrosis
- (2022) Xia Guo et al. Frontiers in Pharmacology
- Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway
- (2022) Xin Wang et al. Bioengineered
- Management of BMI Is a Potential New Approach for the Prevention of Idiopathic Pulmonary Fibrosis
- (2022) Yuchao Ma et al. Frontiers in Genetics
- Contribution of Adiponectin/Carnitine Palmityl Transferase 1A-Mediated Fatty Acid Metabolism during the Development of Idiopathic Pulmonary Fibrosis
- (2022) Wenjuan Wu et al. Oxidative Medicine and Cellular Longevity
- Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis
- (2022) Verónica Pulito-Cueto et al. Frontiers in Molecular Biosciences
- Leptin in Leanness and Obesity
- (2021) Nikolaos Perakakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
- (2021) Ryan S. Dhindsa et al. Communications Biology
- Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation
- (2021) Minghao Xie et al. DIGESTIVE DISEASES AND SCIENCES
- MCP-1: Function, regulation, and involvement in disease
- (2021) Sanjiv Singh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
- (2021) Veronika W. Skrivankova et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adiponectin in renal fibrosis
- (2020) Huan Jing et al. Aging-US
- Resistin family proteins in pulmonary diseases
- (2020) Qing Lin et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Genetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity
- (2020) Hanieh Yaghootkar et al. DIABETES
- Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment
- (2020) Miriana d’Alessandro et al. IMMUNOBIOLOGY
- Causal association of adipokines with osteoarthritis: a Mendelian randomization study
- (2020) Jiayao Fan et al. RHEUMATOLOGY
- Inflammation and Immunity in IPF Pathogenesis and Treatment
- (2019) P. Heukels et al. RESPIRATORY MEDICINE
- Resistin: A reappraisal
- (2019) E. Acquarone et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis
- (2019) Noriyuki Enomoto et al. Scientific Reports
- Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients
- (2019) Tejaswini Kulkarni et al. PLoS One
- Leptin promotes pulmonary fibrosis development by inhibiting autophagy via PI3K/Akt/mTOR pathway
- (2018) Xianhua Gui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
- (2018) Marie Verbanck et al. NATURE GENETICS
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mendelian Randomization
- (2017) Connor A. Emdin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Illustrating, Quantifying, and Correcting for Bias in Post-hoc Analysis of Gene-Based Rare Variant Tests of Association
- (2017) Kelsey E. Grinde et al. Frontiers in Genetics
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
- (2016) Jack Bowden et al. GENETIC EPIDEMIOLOGY
- Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2016) Mengshu Cao et al. MEDIATORS OF INFLAMMATION
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
- (2015) J. Bowden et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Adiponectin Attenuates Lung Fibroblasts Activation and Pulmonary Fibrosis Induced by Paraquat
- (2015) Rong Yao et al. PLoS One
- Adipokines in health and disease
- (2015) Mathias Fasshauer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals
- (2012) Zari Dastani et al. PLoS Genetics
- Leptin Promotes Fibroproliferative Acute Respiratory Distress Syndrome by Inhibiting Peroxisome Proliferator–activated Receptor-γ
- (2011) Manu Jain et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Avoiding bias from weak instruments in Mendelian randomization studies
- (2011) Stephen Burgess et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
- (2007) Debbie A. Lawlor et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started